(Q68723230)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3457647%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

title

Low dose oral administration of 4-demethoxydaunorubicin (idarubicin) in advanced cancer patients. A pharmacokinetic study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3457647%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

1 reference

F Pannuti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3457647%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

C M Camaggi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3457647%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

E Strocchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3457647%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

R Comparsi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3457647%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

B Angelelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3457647%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

M A Pacciarini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3457647%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3457647%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

26 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3457647%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3457647%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3457647%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

page(s)

295-299

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3457647%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00293996

26 September 2019

exact match

0 references

cites work

Phase I study of 4-demethoxydaunorubicin

1 reference

12 December 2020

The new anthracycline 4-demethoxydaunorubicin by oral route in advanced pretreated breast cancer and melanoma. A pilot study

1 reference

12 December 2020

Pharmacokinetic studies of 4'-epi-doxorubicin in cancer patients with normal and impaired renal function and with hepatic metastases

1 reference

12 December 2020

Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers

1 reference

12 December 2020

Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia

1 reference

12 December 2020

Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancer

1 reference

12 December 2020

Antitumor activity of 4-demethoxydaunorubicin administered orally

1 reference

12 December 2020

Separation, characterization, and analysis of epirubicin (4'-epidoxorubicin) and its metabolites from human urine

1 reference

12 December 2020

Epirubicin plasma and blood pharmacokinetics after single i.v. bolus in advanced cancer patients.

1 reference

12 December 2020

Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer

1 reference

12 December 2020

Phase I trial of 4-demethoxydaunorubicin with single i.v. doses

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00293996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3457647%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

1 reference